Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 to 85

MitoQ and ischemic conditioning to improve vascular health after stroke

Official title: MitoQ and Ischemic Conditioning To Assess Vascular Health Outcomes (MITO Study)

Run by Medical College of Wisconsin · NCT06930638 · Data updated 2026-11-12

This project will test whether a brief session of limb ischemic conditioning or taking the antioxidant MitoQ can improve blood vessel function in adults who had a stroke at least six months ago.

More Stroke trials

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment30 (estimated)
SponsorMedical College of Wisconsin
Academic / other
Locations1 site (Milwaukee, Wisconsin)
StatusRecruiting
StartedJuly 22, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedSeptember 25, 2025
Trial IDNCT06930638 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are English-speaking adults aged 18–85 who had a cortical or subcortical stroke at least six months ago with residual hemiparesis and who can follow commands and stand without physical assistance.

Probably not a fit

People with contraindications to limb compression, peripheral vascular disease, recent myocardial infarction or arrhythmia, uncontrolled high blood pressure, significant comorbid neurological disorders, recent severe COVID-19 hospitalization, or who are pregnant or breastfeeding are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this Phase 2 interventional trial, adults with chronic cortical or subcortical stroke and residual hemiparesis will receive a single bout of ischemic conditioning or oral MitoQ supplementation to examine effects on vascular function. Researchers will measure outcomes such as flow-mediated dilation, microvascular blood flow, and muscle activity before and after the interventions. The protocol targets safety and short-term physiological changes that might underlie improved exercise tolerance and lower secondary cardiovascular risk. The study is conducted at the Medical College of Wisconsin and focuses on objective vascular measures rather than clinical recovery endpoints.

Why it matters

Potential benefit: If successful, these interventions could improve vascular function and muscle activity after stroke, which may reduce secondary cardiovascular risk and improve exercise tolerance.

How similar studies have gone: Preliminary data and small studies suggest single bouts of ischemic conditioning or MitoQ may improve vascular function, but larger confirmatory trials are still needed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 - 85 years of age
* Cortical or sub-cortical stroke ≥ 6 months ago with residual hemiparesis
* Able to give informed consent and follow 2-step command.
* English Speaking

Exclusion Criteria:

* Unable to stand from chair without physical assistance from another person (able to use assistive device).
* History of blood clots in the extremities or any condition in which compression of the thigh or transient ischemia is contraindicated (i.e., wounds in the leg).
* Chronic lasting symptoms (\> 6 months) of severe COVID-19 (i.e., hospitalization)
* History of head trauma or concussion within the past 6 months
* Comorbid neurological disorder
* Peripheral vascular disease
* Myocardial infarction or arrhythmia in the previous year
* Resting SBP ≥180 mmHg or DBP ≥ 100 mmHg
* Pregnant or breastfeeding.
* Other significant medical condition likely to influence study or jeopardize safety as assessed by the Primary Investigator

Where it's running

  • Medical College of Wisconsin
    Milwaukee, Wisconsin, United States
    Recruiting

Study contacts

  • Principal investigator: Matthew Durand, PhD — Medical College of Wisconsin
  • Study coordinator: Jennifer Nguyen
  • Email: jnguyen@mcw.edu
  • Phone: 414-955-5713

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.